Literature DB >> 28336561

Mice Lacking the Inhibitory Collagen Receptor LAIR-1 Exhibit a Mild Thrombocytosis and Hyperactive Platelets.

Christopher W Smith1, Steven G Thomas1, Zaher Raslan1, Pushpa Patel1, Maxwell Byrne1, Marie Lordkipanidzé1, Danai Bem1, Linde Meyaard1, Yotis A Senis1, Steve P Watson1, Alexandra Mazharian2.   

Abstract

OBJECTIVE: Leukocyte-associated immunoglobulin-like receptor-1 (LAIR-1) is a collagen receptor that belongs to the inhibitory immunoreceptor tyrosine-based inhibition motif-containing receptor family. It is an inhibitor of signaling via the immunoreceptor tyrosine-based activation motif-containing collagen receptor complex, glycoprotein VI-FcRγ-chain. It is expressed on hematopoietic cells, including immature megakaryocytes, but is not detectable on platelets. Although the inhibitory function of LAIR-1 has been described in leukocytes, its physiological role in megakaryocytes and in particular in platelet formation has not been explored. In this study, we investigate the role of LAIR-1 in megakaryocyte development and platelet production by generating LAIR-1-deficient mice. APPROACH AND
RESULTS: Mice lacking LAIR-1 exhibit a significant increase in platelet counts, a prolonged platelet half-life in vivo, and increased proplatelet formation in vitro. Interestingly, platelets from LAIR-1-deficient mice exhibit an enhanced reactivity to collagen and the glycoprotein VI-specific agonist collagen-related peptide despite not expressing LAIR-1, and mice showed enhanced thrombus formation in the carotid artery after ferric chloride injury. Targeted deletion of LAIR-1 in mice results in an increase in signaling downstream of the glycoprotein VI-FcRγ-chain and integrin αIIbβ3 in megakaryocytes because of enhanced Src family kinase activity.
CONCLUSIONS: Findings from this study demonstrate that ablation of LAIR-1 in megakaryocytes leads to increased Src family kinase activity and downstream signaling in response to collagen that is transmitted to platelets, rendering them hyper-reactive specifically to agonists that signal through Syk tyrosine kinases, but not to G-protein-coupled receptors.
© 2017 American Heart Association, Inc.

Entities:  

Keywords:  LAIR-1; immunoreceptor tyrosine-based activation motif; immunoreceptor tyrosine-based inhibition motif; platelet hyperactivity, Src Family Kinase; thrombocytosis

Mesh:

Substances:

Year:  2017        PMID: 28336561     DOI: 10.1161/ATVBAHA.117.309253

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  13 in total

1.  Diacylglycerol kinase ζ is a negative regulator of GPVI-mediated platelet activation.

Authors:  Alyssa J Moroi; Nicole M Zwifelhofer; Matthew J Riese; Debra K Newman; Peter J Newman
Journal:  Blood Adv       Date:  2019-04-09

2.  Maintenance of murine platelet homeostasis by the kinase Csk and phosphatase CD148.

Authors:  Jun Mori; Zoltan Nagy; Giada Di Nunzio; Christopher W Smith; Mitchell J Geer; Rashid Al Ghaithi; Johanna P van Geffen; Silke Heising; Luke Boothman; Bibian M E Tullemans; Joao N Correia; Louise Tee; Marijke J E Kuijpers; Paul Harrison; Johan W M Heemskerk; Gavin E Jarvis; Alexander Tarakhovsky; Arthur Weiss; Alexandra Mazharian; Yotis A Senis
Journal:  Blood       Date:  2018-01-04       Impact factor: 22.113

3.  TREM-like transcript 1: a more sensitive marker of platelet activation than P-selectin in humans and mice.

Authors:  Christopher W Smith; Zaher Raslan; Lola Parfitt; Abdullah O Khan; Pushpa Patel; Yotis A Senis; Alexandra Mazharian
Journal:  Blood Adv       Date:  2018-08-28

Review 4.  Platelet Signaling Pathways and New Inhibitors.

Authors:  Steven P Grover; Wolfgang Bergmeier; Nigel Mackman
Journal:  Arterioscler Thromb Vasc Biol       Date:  2018-04       Impact factor: 8.311

5.  TNF-α-driven inflammation and mitochondrial dysfunction define the platelet hyperreactivity of aging.

Authors:  Pavel Davizon-Castillo; Brandon McMahon; Sonia Aguila; David Bark; Katrina Ashworth; Ayed Allawzi; Robert A Campbell; Emilie Montenont; Travis Nemkov; Angelo D'Alessandro; Nathan Clendenen; Lauren Shih; Natalie A Sanders; Kelly Higa; Allaura Cox; Zavelia Padilla-Romo; Giovanni Hernandez; Eric Wartchow; George D Trahan; Eva Nozik-Grayck; Kenneth Jones; Eric M Pietras; James DeGregori; Matthew T Rondina; Jorge Di Paola
Journal:  Blood       Date:  2019-07-16       Impact factor: 22.113

6.  Antithrombotic Effects of Fostamatinib in Combination with Conventional Antiplatelet Drugs.

Authors:  Maan H Harbi; Christopher W Smith; Fawaz O Alenazy; Phillip L R Nicolson; Alok Tiwari; Steve P Watson; Mark R Thomas
Journal:  Int J Mol Sci       Date:  2022-06-23       Impact factor: 6.208

Review 7.  Mouse laser injury models: variations on a theme.

Authors:  Timothy J Stalker
Journal:  Platelets       Date:  2020-04-16       Impact factor: 3.862

8.  Reporting Sex and Sex Differences in Preclinical Studies.

Authors:  Hong S Lu; Ann Marie Schmidt; Robert A Hegele; Nigel Mackman; Daniel J Rader; Christian Weber; Alan Daugherty
Journal:  Arterioscler Thromb Vasc Biol       Date:  2018-10       Impact factor: 8.311

Review 9.  ITIM receptors: more than just inhibitors of platelet activation.

Authors:  Carmen H Coxon; Mitchell J Geer; Yotis A Senis
Journal:  Blood       Date:  2017-05-02       Impact factor: 22.113

10.  Single-cell RNA sequencing shows the immunosuppressive landscape and tumor heterogeneity of HBV-associated hepatocellular carcinoma.

Authors:  Daniel Wai-Hung Ho; Yu-Man Tsui; Lo-Kong Chan; Karen Man-Fong Sze; Xin Zhang; Jacinth Wing-Sum Cheu; Yung-Tuen Chiu; Joyce Man-Fong Lee; Albert Chi-Yan Chan; Elaine Tin-Yan Cheung; Derek Tsz-Wai Yau; Nam-Hung Chia; Irene Lai-Oi Lo; Pak-Chung Sham; Tan-To Cheung; Carmen Chak-Lui Wong; Irene Oi-Lin Ng
Journal:  Nat Commun       Date:  2021-06-17       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.